CD4 and hepatocellular carcinoma: Accordingly, CD14+ cytotoxic T-lymphocyte-associated protein (CTLA)-4+ DCs, a subset recently identified, are over-represented in tumoral tissue of HCC patients and are involved in the production of some regulatory cytokines (e.g., IL-10), which suppress the CD4+ T-cell immune response, facilitating the tumor progression [172].